BioPlus Acquisition Corp.
BIOS · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $0 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $1 |
| Total Curr. Assets | $0 | $0 | $1 | $1 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $238 | $236 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $138 | $240 | $0 | $0 |
| Total NC Assets | $138 | $240 | $238 | $236 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $139 | $241 | $238 | $237 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $1 |
| Other Curr. Liab. | $2 | $1 | $1 | $0 |
| Total Curr. Liab. | $2 | $1 | $1 | $0 |
| LT Debt | $5 | $5 | $5 | $5 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $10 | $10 | $10 | $10 |
| Total NC Liab. | $15 | $15 | $15 | $15 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $17 | $16 | $15 | $15 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $138 | $240 | $238 | $236 |
| Retained Earnings | -$17 | -$15 | -$15 | -$14 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $122 | $225 | $223 | $221 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $139 | $241 | $238 | $237 |
| Net Debt | $5 | $5 | $5 | $5 |